• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    |
    Weekly News Recap #Phispers
    Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

    Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

    In Phispers this week, the US Food and Drug Administration (FDA) approved Eli Lilly’s Foundayo (orforglipron), a once-dai...

    Impressions : 1357

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.